EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7
AffiliationDepartment of Molecular and Cell Biology, University of Leicester, Lancaster Road, Leicester LE1 9HN
MetadataShow full item record
CitationNoyes J, Allen D, Carter C, Edwards D, Edwards RT, Russell D, et al. Standardised self-management kits for children with type 1 diabetes: pragmatic randomised trial of effectiveness and cost-effectiveness. BMJ Open. 2020;10:e032163.
JournalJournal of Cell Science
- Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC.
- Authors: Zhang SS, Nagasaka M, Zhu VW, Ou SI
- Issue date: 2021 Aug
- EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non-small cell lung cancer.
- Authors: Christopoulos P, Endris V, Bozorgmehr F, Elsayed M, Kirchner M, Ristau J, Buchhalter I, Penzel R, Herth FJ, Heussel CP, Eichhorn M, Muley T, Meister M, Fischer JR, Rieken S, Warth A, Bischoff H, Schirmacher P, Stenzinger A, Thomas M
- Issue date: 2018 Jun 15
- Microtubule association of EML proteins and the EML4-ALK variant 3 oncoprotein require an N-terminal trimerization domain.
- Authors: Richards MW, O'Regan L, Roth D, Montgomery JM, Straube A, Fry AM, Bayliss R
- Issue date: 2015 May 1
- Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer.
- Authors: Tan S, Sun D, Pu W, Gou Q, Guo C, Gong Y, Li J, Wei YQ, Liu L, Zhao Y, Peng Y
- Issue date: 2018 Sep 20
- Correlation of anaplastic lymphoma kinase overexpression and the EML4-ALK fusion gene in non-small cell lung cancer by immunohistochemical study.
- Authors: Chen TD, Chang IC, Liu HP, Wu YC, Wang CL, Chen YT, Chen YR, Huang SF
- Issue date: 2012 Jul-Aug